Arbutus Biopharma Corporation

NASDAQ: ABUS
Share price (1/7/25): $3.41
Market cap (1/7/25): $646 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Shelf registration

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Two Seas Capital LP

Manchester Keith S

Burgess Daniel D

Manchester Keith S

News Filter

Arbutus’ Imdusiran Achieves Functional Cure in cHBV Patients When Combined With a Short Course of Interferon

Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Announces Multiple Abstracts Highlighting Imdusiran Data Accepted for Presentation at AASLD - The Liver Meeting® 2024

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Material Disclosure

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness